VNET Group, Inc. Earnings Presentation for 4Q24 and FY2024 March 12, 2025 Disclaimer This presentation has been prepared by VNET Group, Inc. (the "Company") solely for informational purposes and has not been independently verified. No representations, warranties or undertakings, express or implied, are made by the Company or any of its affiliates, advisers or representatives as to, and no reliance should be placed upon, the accuracy, fairness, completeness or correctness of the information or opinions prese ...

FOURTH QUARTER 2024 FORWARD-LOOKING STATEMENTS Please note that in this presentation we may use words such as "appears," "anticipates," "believes," "plans," "expects," "intends," "future," and similar expressions which constitute forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are made based on our expectations and beliefs concerning future events impacting the Company and therefore involve a numb ...

Fourth Quarter 2024 Earnings Presentation March 12, 2025 Management Report 2025 CONFIDENTIAL Forward Looking Statements This presentation contains certain statements that may be deemed to be "forward - looking statements" within the meaning of applicable federal securities laws . Most forward -looking statements contain words that identify them as forward -looking, such as "may", "plan", "seek", "will", "expect", "intend", "estimate", "anticipate", "believe", "project", "opportunity", "target", "goal", "gro ...

Magnachip Semiconductor (NYSE: MX) Q4 2024 and 2024 Earnings Materials March 12, 2025 1 Forward-Looking Statements Information in this presentation regarding Magnachip's forecasts, business outlook, expectations and beliefs are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. All forward-looking statements included or incorporated by reference in this presentation, including expectations about estimated historical or ...

First Quarter 2025 Earnings Presentation March 12, 2025 Forward Looking Statements This press release contains both historical and forward-looking statements about ABM Industries Incorporated ("ABM") and its subsidiaries (collectively referred to as "ABM," "we," "us," "our," or the "Company"). We make forward-looking statements related to future expectations, estimates and projections that are uncertain, and often contain words such as "anticipate," "believe," "could," "estimate," "expect," "forecast," "int ...

Safe Harbor Statement FORWARD-LOOKING STATEMENTS Statements in this presentation that relate to goals, strategies, future plans and expectations are based on Korn Ferry's current expectations. You are cautioned not to place undue reliance on such statements. Actual results in future periods may differ materially from those currently expected because of a number of risks and uncertainties. For a detailed description of many of those risks and uncertainties, please refer to Korn Ferry's earnings release and i ...

Financial Performance & Metrics - Stitch Fix reported net revenue of $1.34 billion for fiscal year 2024[18] - The company's active clients totaled 2.5 million[18] - Revenue per active client (RPAC) was $533[18] - Gross margin expanded to 44.3% in fiscal year 2024[18, 24] - Adjusted EBITDA margin was 2.2% in fiscal year 2024[18] - Free cash flow generated was $14.2 million in fiscal year 2024[24] - For fiscal Q2 2025, net revenue was $312 million[40] - For fiscal Q2 2025, active clients totaled 2.4 million[40] Market Opportunity - The U.S apparel, footwear, and accessories market is valued at $369.9 billion in 2024[26] - The U.S apparel market is valued at $244.6 billion in 2024[26] - The U.S apparel & footwear market is valued at $335.0 billion in 2024[26]

Company Overview - Zynex's share price was $10.10 as of July 22, 2024, with a market capitalization of $321 million[4] - The company's trailing twelve months (TTM) revenue as of June 30, 2024, was $193 million, with a gross margin of 80% and a net income of $6 million[4] - Zynex has $30.8 million in cash and cash equivalents as of June 30, 2024[4] - Insider holdings account for 51.5% of outstanding shares[4] Market and Growth - Zynex operates in an addressable market exceeding $4.6 billion, presenting high growth opportunities[5] - The electrotherapy market size is $950 million, excluding stroke treatment[10, 11] - The patient monitoring market size is $3.6 billion, excluding sepsis[10, 11] - The company's revenue has grown at a 4-year compound annual growth rate (CAGR) of 42%[5] Financial Performance - Zynex's TTM EBITDA is $22.4 million[5] - In 2023, 68% of Zynex's revenue came from supplies[15] - The company's revenue increased from $45.5 million in 2019 to $184.3 million in 2023, representing a 42% CAGR[50] - Zynex is targeting sales reps to achieve >$1 million in revenue per rep[36]

4Q 2024 INVESTOR PRESENTATION March 11, 2025 DISCLAIMER Forward-Looking Statements and Other Information This presentation and the related management commentary contain, and responses to investor questions may contain, forward-looking statements that can be identified by the fact that they do not relate strictly to historical or current facts and may contain the words "believe," "anticipate," "expect," "intend," "plan," "predict," "estimate," "project," "will be," "will continue," "will likely result," or o ...

Q4 & FYE 2024 Earnings Call March 11, 2025 Forward Looking Statements Statements included herein, including statements regarding SuRo Capital Corp.'s ("SuRo Capital", "SSSS", "we", "us" or "our") beliefs, expectations, intentions or strategies for the future, may constitute "forward-looking statements". SuRo Capital cautions you that forward-looking statements are not guarantees of future performance and that actual results or developments may differ materially from those projected or implied in these state ...